0001209191-21-045825.txt : 20210707 0001209191-21-045825.hdr.sgml : 20210707 20210707164635 ACCESSION NUMBER: 0001209191-21-045825 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210702 FILED AS OF DATE: 20210707 DATE AS OF CHANGE: 20210707 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scavilla Daniel T CENTRAL INDEX KEY: 0001642439 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35621 FILM NUMBER: 211077911 MAIL ADDRESS: STREET 1: C/O GLOBUS MEDICAL, INC. STREET 2: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBUS MEDICAL INC CENTRAL INDEX KEY: 0001237831 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043744954 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 BUSINESS PHONE: 610-930-1800 MAIL ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-02 0 0001237831 GLOBUS MEDICAL INC GMED 0001642439 Scavilla Daniel T VALLEY FORGE BUSINESS CENTER 2560 GENERAL ARMISTEAD AVENUE AUDUBON PA 19403 0 1 0 0 EVP, Chief Commercial Officer Class A Common Stock 2021-07-02 4 M 0 50000 25.52 A 50000 D Class A Common Stock 2021-07-02 4 M 0 50000 26.27 A 100000 D Class A Common Stock 2021-07-02 4 S 0 99600 78.41 D 400 D Class A Common Stock 2021-07-02 4 S 0 400 78.97 D 0 D Stock Option (Right to buy Class A Common Stock) 25.52 2021-07-02 4 M 0 50000 0.00 D 2026-01-25 Class A Common Stock 50000 0 D Stock Option (Right to Buy Class A Common Stock) 26.27 2021-07-02 4 M 0 50000 0.00 D 2027-01-30 Class A Common Stock 50000 30000 D This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.83 to $78.69, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. /s/ Kelly G. Huller, Attorney-in-Fact 2021-07-07